Find information on the dosing and administration of ADSTILADRIN®, including instillation details. See Important Safety Info.

Oct 10, 2025 · Detailed dosage guidelines and administration information for Adstiladrin (nadofaragene firadenovec-vncg). Includes dose adjustments, warnings and precautions.

2 DOSAGE AND ADMINISTRATION Important Administration Instructions ADSTILADRIN is for intravesical instillation only. ADSTILADRIN is not for intravenous use, topical use, or oral …

Oct 10, 2025 · ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation. It is a recombinant adenovirus serotype …

Medscape - Bladder cancer dosing for Adstiladrin (nadofaragene firadenovec), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation …

Dosing and Administration The recommended dose of Adstiladrin is 75 mL at a concentration of 3 x 1011 viral particles (vp)/mL instilled once every 3 months into the bladder via a urinary …

May 4, 2023 · Dosing Limits Quantity Limit (max daily dose) [NDC Unit]: − Adstiladrin suspension 3 × 1011 viral particles (vp)/mL (20 mL single-dose vial): 4 vials every three months for four …

Dosage interruptions of ADSTILADRIN due to an adverse reaction occurred in 54 (34%) patients. Adverse reactions in >10% of patients that required dosage interruption included instillation …

Jun 19, 2023 · Adstiladrin (Nadofaragene Firadenovec-vncg Suspension, for Intravesical Use) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and …

DOSAGE AND ADMINISTRATION: Administer ADSTILADRIN by intravesical instillation only. ADSTILADRIN is not for intravenous use, topical use, or oral administration. USE IN …